| London Stock Exchange: IMM
ImmuPharma Plc is a drug discovery and development company, which is focused on developing novel medicines to treat serious medical conditions and address a high unmet need. The company develops drugs to treat lupus, cancer, severe pain, highly resistant infections like MRSA and inflammatory and allergic disorders. It has research operations in France and Switzerland. ImmuPharma was founded by Richard Warr in 1999 and is headquartered in London, the United Kingdom.